Immatics

Personalized T-cell therapy clears metastatic kidney cancer in teen

Researchers at the Hopp Children's Cancer Center Heidelberg have achieved complete remission of advanced, treatment-resistant kidney cancer in an adolescent using a personalized T-cell therapy targeting the PRAME antigen, according to results published August 12 in the New England Journal…